London, United Kingdom and Newport Beach, California - October 8 2026

Sage Healthcare Ltd ("Sage") and Roth Capital Partners, LLC ("Roth") have announced a strategic collaboration to identify and assess European healthcare and life-science companies that may benefit from experienced transaction advice and U.S. capital markets expertise.

Sage will contribute access to its European network, transaction experience and SAGEIQ™, its AI-enabled company identification and prioritisation capability. Roth will provide access to its healthcare investment banking, financing strategy and U.S. capital markets services, subject to its compliance and client-acceptance procedures.

Management Comments

“European healthcare and life-science companies often need strategic transaction advice alongside U.S. capital markets expertise,” said Dr. William Mason, Director of Sage Healthcare Ltd. “This collaboration allows us to explore where Sage’s network and experience may complement Roth’s platform.”

“Sage’s experience, European network and intelligence capabilities may identify companies that could benefit from Roth’s healthcare investment banking and U.S. capital markets expertise,” said Dr. Ben Bowen, Managing Director, Investment Banking at Roth Capital Partners. “We look forward to assessing relevant opportunities together.”

About Sage Healthcare Ltd

Sage Healthcare Ltd is a specialist healthcare and life-science transaction advisory firm supporting licensing, partnering and M&A. Its SAGEIQ™ capability supports company and partner prioritisation.

For more information, please visit: www.sagehealthcare.com

About Roth Capital Partners, LLC

Roth Capital Partners, LLC is a Newport Beach-based investment banking and capital markets firm providing financing and strategic financial advisory services to healthcare growth companies.

For more information, please visit: www.roth.com

Contacts